SARS COV2/Influenza A/B and RSV RNA QL NAAT
Also known as: Novel Coronavirus, Wuhan, COVID 19, SARS, Flu A/B
Use
This multitarget molecular test aids in simultaneous qualitative detection and differentiation of SARS‑CoV‑2 (COVID‑19), influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA. It is intended for use with respiratory specimens collected from individuals suspected of respiratory viral infection (COVID‑19, influenza or RSV), as clinical signs and symptoms can be similar across these pathogens. ([intellitestmanager.questdiagnostics.com](https://intellitestmanager.questdiagnostics.com/home/output/219098?utm_source=openai))
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
PCR-based (RT-PCR)
Biomarkers
LOINC Codes
- 92131-2
- 92141-1
- 92142-9
- 94500-6
- 92142-9
- 92141-1
- 92131-2
- 94500-6
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Nasal Swab
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
One (1) nasopharyngeal or nasal swab collected in VCM, UTM or equivalent media. Specimens should be transported refrigerated.
Causes for Rejection
Calcium alginate swabs; cotton swabs in wooden shaft; Amies liquid or gel transport for bacterial cultures; tubes with clot activator; glass tubes; snap‑cap tubes; 3D printed swabs; media with guanidine isothiocyanate (GITC) due to safety concerns; specimen at room temperature > 24 hours; throat and lower respiratory samples; transport tube with the swab inverted
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 7 days |
| Frozen | Acceptable at –70 °C |